EMEA-001900-PIP02-17-M06
Key facts
| Invented name |
Adtralza
|
| Active substance |
Tralokinumab
|
| Therapeutic area |
Dermatology
|
| Decision number |
P/0096/2022
|
| PIP number |
EMEA-001900-PIP02-17-M06
|
| Pharmaceutical form(s) |
Solution for injection
|
| Condition(s) / indication(s) |
Treatment of atopic dermatitis
|
| Route(s) of administration |
Subcutaneous use
|
| Contact for public enquiries |
LEO Pharma A/S
Tel. +45 44945888 E-mail: raleodk@leo-pharma.com |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|